天然产物 糖类和糖苷 Saccharides and Glycosides
Kanamycin sulfate;(Synonyms: 硫酸卡那霉素; Kanamycin A monosulfate) 纯度: ge;98.0%
Kanamycin sulfate是氨基糖苷类杀菌抗生素,其通过与细菌30S核糖体结合起作用。
Kanamycin sulfate Chemical Structure
CAS No. : 25389-94-0
规格 | 价格 | 是否有货 | 数量 |
---|---|---|---|
Free Sample (0.1-0.5 mg) | ; | Apply now | ; |
10;mM;*;1 mL in Water | ¥500 | In-stock | |
200 mg | ¥350 | In-stock | |
1 g | ¥450 | In-stock | |
5 g | ¥880 | In-stock | |
10 g | ; | 询价 | ; |
50 g | ; | 询价 | ; |
* Please select Quantity before adding items.
Kanamycin sulfate 相关产品
bull;相关化合物库:
- Natural Product Library Plus
- Drug Repurposing Compound Library Plus
- FDA-Approved Drug Library Plus
- FDA-Approved Drug Library Mini
- Bioactive Compound Library Plus
- Anti-Infection Compound Library
- Natural Product Library
- FDA-Approved Drug Library
- Drug Repurposing Compound Library
- Glycoside Compound Library
- Antibacterial Compound Library
- Anti-COVID-19 Compound Library
- NMPA-Approved Drug Library
- FDA Approved amp; Pharmacopeial Drug Library
- Antibiotics Library
- Drug-Induced Liver Injury (DILI) Compound Library
- Microbial Metabolite Library
- Rare Diseases Drug Library
生物活性 |
Kanamycin sulfate is an aminoglycoside bacteriocidal antibiotic which acts by binding to the bacterial 30S ribosomes. |
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
体外研究 (In Vitro) |
Kanamycin sulfate at the concentration above 0.0025% has a significant inhibition on the growth of B. bifidum and has no influence on the other four probiotics at incubation 12 h or 24 h. The optimum selective concentration of kanamycin sulfate in MRS media is 0.005% for selective enumeration of B.bifidum[3]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
体内研究 (In Vivo) |
The neurons damage of the DCN caused by kanamycin (500 mg/kg/day) is reversible and autophagy is upregulated in the neurotoxic course of kanamycin on DCN through JNK1-mediated phosphorylation of Bcl-2 pathway in rats. The serum BUN and Cr levels are both increased at the 1st day after the period of kanamycin administration. The neurons expressing LC3 are increased at 1, 7 and 14 days after kanamycin administration in comparison to the control group. Kanamycin treatment results in the increase of autophagy in a time-dependent manner[1]. Kanamycin sulfate (5 mg/kg) and sodium ampicillin (10 mg/kg) administered intramuscularly (i.m.) separately, and then together, to five pony mares, and the ampicillin concentration exceeds 5 mg/mL in inflamed synovial fluid for some 2.5 h after injection, and kanamycin sulfate concentration exceeds 2 mg/mL for 7 h in the pony[2]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||
Clinical Trial |
|
||||||||||||||||
分子量 |
582.58 |
||||||||||||||||
Formula |
C18H38N4O15S |
||||||||||||||||
CAS 号 |
25389-94-0 |
||||||||||||||||
中文名称 |
硫酸卡那霉素;单硫酸卡那霉素;硫酸卡那辛 |
||||||||||||||||
运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
储存方式 |
4deg;C, sealed storage, away from moisture *In solvent : -80deg;C, 6 months; -20deg;C, 1 month (sealed storage, away from moisture) |
||||||||||||||||
溶解性数据 |
In Vitro:;
H2O : 100 mg/mL (171.65 mM; Need ultrasonic) DMSO : < 1 mg/mL (insoluble or slightly soluble) 配制储备液
*
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
*以上所有助溶剂都可在 MCE 网站选购。
|
||||||||||||||||
参考文献 |
|
Animal Administration [1] |
Sixty-six male Sprague-Dawley rats (initial body weight 125-150 g, 5-6 weeks old) have free access to water and a regular diet, and are allowed 1 week of acclimation before the first treatment. The animals are divided randomly into one control group and seven experimental groups. Control group rats (n=10) are injected subcutaneously with an equal volume of vehicle (0.9% saline) for 10 days as those in the groups of kanamycin treatment, but without kanamycin. The experimental groups (n=56, 8 for each group: 1, 7, 14, 28, 56, 70 and 140 days after kanamycin administration, respectively) receive 500 mg of kanamycin sulfate/kg/day by subcutaneous injection for 10 days. The animal body weight is monitored every day and the injection dosage of kanamycin is adjusted accordingly. Auditory thresholds are tested by ABR. The tests are taken twice for each animal, first prior to the beginning of administration and then at different observing time points after kanamycin treatment. Details for the ABR measurement is described elsewhere. MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
---|---|
参考文献 |
|